Fig. 2From: Analytical quality-by-design approach for development and validation of HPLC method for the simultaneous estimation of omarigliptin, metformin, and ezetimibe: application to human plasma and dosage formsTypical chromatograms of (a) Mixture of OMG, MET, and EZT (25.0 µg/mL of each one) and (b) Mixture of OMG (0.5 µg/mL), MET (10.0 µg/mL), and EZT (0.2 µg/mL) at the optimum chromatographic conditionsBack to article page